can act as a signalling hub 1 , but its exact role in many of the described pathways has remained elusive. Here, we investigate the mechanism of cilia-mediated regulation of the canonical Wnt pathway. We found that primary cilia dampen canonical Wnt signalling through a spatial mechanism involving compartmentalization of signalling components. The cilium, through regulated intraflagellar transport, diverts Jouberin (Jbn), a ciliopathy protein and context-specific Wnt pathway regulator 2 , away from the nucleus and limits β-catenin nuclear entry. This repressive regulation does not silence the pathway, but instead maintains a discrete range of Wnt responsiveness; cells without cilia have potentiated Wnt responses, whereas cells with multiple cilia have inhibited responses. Furthermore, we show that this regulation occurs during embryonic development and is disrupted in cancer cell proliferation. Together these data explain a spatial mechanism of Wnt signalling regulation that may provide insight into ciliary regulation of other signalling pathways.
The Wnt signalling pathway functions in a variety of cellular processes, and mutations in this pathway have been identified in a broad array of illnesses, from developmental disorders to cancer 3, 4 . Primary cilia have been connected with a variety of disorders known as ciliopathies 5, 6 , and have been implicated in negative regulation of the canonical Wnt pathway [7] [8] [9] . However, in other models of cilia disruption such regulation of the Wnt pathway has not been apparent 10, 11 , indicating potential context or evolutionary dependency.
To examine this discrepancy, as well as subcellular mechanisms, we assayed canonical Wnt signalling with disruption of specific aspects of ciliary function. First, we examined Wnt activity using a luciferase reporter assay 12 in mouse embryonic fibroblasts (MEFs) following serum stimulation to induce ciliary retraction 13 . These deciliated cells (quantified in Supplementary Fig. S1a ) showed exaggerated Wnt activity ( Fig. 1a ), similar to that previously described in non-ciliated cells 8, 9 , indicating that cilia retraction may prime the cell for an increased Wnt response. We next investigated MEFs from mice harbouring an early nonsense mutation in the retrograde transport motor dynein cytoplasmic 2 heavy chain 1 (Dync2h1 also known as Dnchc2) gene 14 . These independently derived cells lacked cilia ( Supplementary Fig. S1b,c) , in contrast to other Dnchc2 MEFs generated by another group from a mouse with a different mutation in the gene 11 . We observed increased Wnt activity in these mutant cells (Fig. 1b ), similar to that previously described for other intraflagellar transport (IFT) mutant MEFs (ref. 9) . Together, these data support a role for cilia in repressing cellular Wnt responsiveness.
We next investigated which point in the pathway cilia may regulate, by treating with lithium, a Gsk3β (glycogen synthase kinase 3β) inhibitor 15 leading to cytosolic accumulation of β-catenin. Cells with retracted cilia and treated with LiCl exhibited increased Wnt activity when compared with ciliated cells (Fig. 1c ). Importantly, lithium can lead to modest cilia lengthening 16 , but we found no effect in these cells ( Supplementary Fig. S1d ). We further examined the effect of LiCl ( Supplementary Fig. S1e ) or overexpression of constitutively active β-catenin (β-Cat N) in Dnchc2 mutant MEFs, which exhibited increased activity when compared with control MEFs (Fig. 1d ). A similar outcome was produced in wild-type MEFs transfected with Kif3a (kinesin family member 3A) siRNA to block cilia formation 8 ( Fig. 1e and Supplementary Fig. S2a,b) . These findings indicate that the primary cilium restrains canonical Wnt signalling at least partially downstream of β-catenin cytosolic stabilization.
We next examined the subcellular localization of β-catenin in ciliated and non-ciliated cells. We observed basal body localization of green fluorescent protein (GFP)-tagged β-catenin ( Fig. 1f,g and Supplementary Fig. S2c ) as well as endogenous β-catenin ( Fig. 1h ) in ciliated cells despite the presence of Wnt ligand, whereas non-ciliated cells exhibited striking nuclear accumulation of β-catenin. Furthermore, an alternative ciliated cell type, mouse inner medullary collecting duct (IMCD) cells, exhibited stronger nuclear β-catenin staining in non-ciliated cells when compared with neighbouring ciliated cells ( Supplementary Fig. S3a,b ). These results indicate that the presence of the cilium represses nuclear accumulation of β-catenin. We previously showed that Jbn, a ciliopathy protein encoded by Ahi1 (refs [17] [18] [19] , facilitates β-catenin nuclear translocation to positively modulate Wnt signalling 2 . As Jbn is the only known modulator of β-catenin that also localizes to cilia, the mechanism of ciliary inhibition may involve Jbn. To test this, we first examined Jbn and β-catenin co-localization in ciliated and non-ciliated cells. Whereas ciliated MEFs exhibited basal body localization of Jbn and β-catenin, Dnchc2 mutant MEFs instead exhibited increased nuclear levels of both Jbn and β-catenin ( Fig. 2a ). These results were further supported by nuclear extraction, which revealed increased nuclear β-catenin and Jbn in Dnchc2 mutant MEFs ( Supplementary Fig. S3c ), whereas total Jbn levels were not increased in mutant MEFs ( Supplementary Fig. S3d ). This indicates that the role of Jbn in the Wnt pathway may be inhibited by the presence of the primary cilium.
To test this hypothesis, we measured Wnt activity in ciliated and non-ciliated cells overexpressing Jbn. We observed increased potentiation by Jbn in MEFs following serum-induced cilia retraction ( Fig. 2a and Supplementary Fig. S4 ). This effect was also evident in ciliated 293T cells 8 ( Supplementary Fig. S4a ,b) or MEFs transfected with Kif3a siRNA (Fig. 2b,c and Supplementary Fig. S4c ), and was also evident in Dnchc2 mutant MEFs ( Fig. 2d ) with activation of the pathway upstream or at the level of β-catenin stabilization. Furthermore, we identified a region within the Jbn protein previously described to act as a ciliary targeting motif in other cilia proteins, with the sequence RVxP (ref. 20) . We mutated all three key residues of this sequence within Jbn, and this mutant, in contrast to the wild-type protein, failed to localize to cilia ( Supplementary Fig. S4d ) but elicited an increased Wnt response in ciliated MEFs ( Fig. 2e ). These results support the hypothesis that the presence of the primary cilium and ciliary localization of Jbn suppress the role of Jbn in Wnt signalling.
As the cilium seems to regulate the subcellular localization of both Jbn and β-catenin, and we identified an association with microtubules ( Supplementary Fig. S4e ), the cilium may act to spatially sequester Jbn. We therefore carried out acute disruption of retrograde IFT, resulting in a redistribution of IFT-transported components owing to their inability to return to the basal body [21] [22] [23] [24] . We carried out siRNA knockdown of Dnchc2 in ciliated fibroblasts to inhibit retrograde transport but leave ciliary structure intact ( Supplementary Fig. S4f ). Using this approach, we observed a redistribution of Jbn along the cilia length ( Fig. 3a) . Importantly, although there was still some cytosolic Jbn present with Dnchc2 knockdown, levels of Jbn within the cilium were significantly increased (Fig. 3a, bottom ). This indicates that the pool of Jbn normally localized in the basal body is sequestered along the ciliary axoneme with inhibition of Dnchc2.
To test whether this sequestration affects Wnt pathway responsiveness, we carried out luciferase experiments in ciliated MEFs transfected with Dnchc2 siRNA. We observed a decreased Wnt response with knockdown of Dnchc2, indicating that intact retrograde IFT is required for Wnt activity in ciliated cells (Fig. 3b ). This effect was also evident in ciliated 293T cells overexpressing Jbn, which failed to potentiate the pathway to the same degree following Dnchc2 knockdown ( Fig. 3c ).
We next examined the basis for the difference in effect between siRNA knockdown and null mutation of Dnchc2 in MEFs. First, we determined the specificity of Dnchc2 knockdown by testing its effect in MEFs not subjected to serum starvation, and therefore lacking cilia, and found no effect ( Supplementary Fig. S5a ). We next investigated whether the degree of knockdown could be the basis for the difference between null mutation and siRNA. We found that increasing the dose of Dnchc2 siRNA threefold resulted in a loss of cilia rather than the specific retrograde transport defects seen with the lower concentration ( Supplementary Fig. S5b ). Furthermore, this high dose led to a switch in Wnt responsiveness such that cells transfected with increased siRNA exhibited increased Wnt activity ( Fig. 3d ).
Our results indicate that, whereas retrograde IFT is required in ciliated cells for Wnt activity, cilia loss leads to increased Wnt responsiveness. This indicates that the cilium may regulate canonical Wnt signalling through dual roles to restrict the range of Wnt activity. To test this further, we examined cells with more than one cilium. We found that treatment of MEFs with the DNA polymerase inhibitor aphidicolin led to the appearance of many cells with two cilia, similar to the effect described with a topoisomerase inhibitor 25 ( Supplementary Fig. S5c,d ). We therefore investigated the effect of this drug in the luciferase assay and observed a marked reduction in Wnt activity when compared with vehicle alone (Fig. 3e,f ). Furthermore, we examined β-catenin localization in cells treated with aphidicolin and found strikingly decreased levels of nuclear β-catenin in biciliated cells (Fig. 3g) .
These findings support a model in which primary cilia maintain a restricted range of Wnt activity through spatial constraint of Jbn and β-catenin ( Fig. 3h ). This model would fit with the observation that ciliated cells exhibited muted Wnt activity but not a complete lack of response. In the absence of cilia, Jbn and β-catenin enter the nucleus without restraint, resulting in exaggerated downstream transcriptional response. Specific inhibition of retrograde IFT instead leads to increased sequestration and therefore a decrease in Wnt response, indicative of a fine balance of Wnt responsiveness in ciliated cells through spatial regulation of Wnt components.
We investigated the physiological relevance of this regulation by examining Dnchc2 mutant (Dnchc2 Q397Stop allele 14 ); BATgal+ (ref. 26) mice for Wnt reporter activity during embryonic development. We selected this mutant because of the specific effect on retrograde IFT (ref. 14 ) . First, we examined BATgal reporter activity by wholemount 5-bromo-4-chloro-3-indolyl-β-d-galactoside (X-gal) staining of embryos at embryonic day (E) 9.5 and E11.5. We observed a decrease in Wnt activity in a subset of tissues, including limb buds, developing hair follicles and mammary glands, whereas other regions, including nasal folds and brain tissue, exhibited increased Wnt activity ( Fig. 4a and Supplementary Fig. S6a ).
To examine cilia in these mutants, we carried out immunostaining for Arl13b (ADP-ribosylation factor-like 13B; ref. 27 ) along with β-galactosidase ( Fig. 4b ). β-galactosidase antibody staining was specific for BATgal+embryos ( Supplementary Fig. S6b ). Dnchc2; BATgal+ mutants exhibited several regions (including limb bud, metanephros and developing lung) that had decreased Wnt activity ( Fig. 4b and Supplementary Fig. S6c ) with abundant but shortened cilia ( Supplementary Fig. S6d ). Furthermore, we stained for β-catenin in the developing kidney of mutants to examine nuclear localization, and similarly observed a decrease in Wnt activity ( Supplementary Fig. S6e ).
Interestingly, some regions, such as brain tissue and nasal folds, exhibited a loss of cilia in these mutants ( Fig. 3b and data not shown) similar to Dnchc2 MEFs, indicating cell-type-specific sensitivity to the absence of Dnchc2. Although the basis of this difference is still under investigation, we observed an increase in Wnt activity in non-ciliated tissues (Fig. 4b ), which is also consistent with the model that cilia generally repress Wnt responsiveness. Furthermore, we observed variability in the severity of phenotypes with more severe mutants exhibiting more extensive cilia loss with associated increased canonical Wnt activity (data not shown). However, we universally observed decreased Wnt activity in regions that maintained cilia, whereas regions with a loss of cilia exhibited increased Wnt activity ( Fig. 4c ). Finally, we examined Kif3a −/− ; BATgal+ embryos, which completely lack cilia 28 , and we observed a similar increase in Wnt activity in all regions examined ( Fig. 4d ). Together, these results indicate that in vivo, specific disruption of retrograde IFT leads to decreased Wnt activity, whereas cilia loss results in increased Wnt signalling.
In addition to its roles in embryonic development, canonical Wnt signalling is also important in the regulation of proliferation and oncogenic transformation. As the cilium has also recently been implicated in proliferation in the context of cancer 29, 30 , and Jbn has previously been identified as an oncogene in specific contexts 31 , the cilium and Jbn may regulate canonical Wnt signalling in cancer cell proliferation as well. To test this, we first examined proliferation of ciliated MEFs transfected with Jbn-GFP or the cilia-localization-deficient RVxP mutant Jbn. We observed an increase in the level of proliferation with mutant overexpression when compared with wild-type Jbn (Fig. 5a ), indicating that ciliary regulation of Jbn and Wnt signalling may represent an important regulator of cellular proliferation. We next investigated the role of Jbn in cancer cell proliferation by examining the well-described colon cancer DLD1 cell line, which harbours a mutation in APC (adenomatous polyposis coli; ref. 32) , and which we found lacked cilia (Fig. 5b ). We carried out Ahi1 knockdown in these cells and observed a decrease in the level of proliferation based on 5-bromodeoxyuridine (BrdU) incorporation and Ki67 levels ( Fig. 5c,d) . Furthermore, β-catenin nuclear levels were decreased in DLD1 cells transfected with Ahi1 siRNA (Fig. 5e) . These results support a role for Jbn in Wnt-mediated cancer cell proliferation. Moreover, as DLD1 cells lacked cilia, one intriguing hypothesis is that cilia loss may represent an important step in transformation of cancer cells such as DLD1 cells, because it may exacerbate Wnt defects. Indeed, we found many cilia in healthy primary human colon cells, in contrast to DLD1 cells (Fig. 5f ). Supplementary Fig. S7 .
L E T T E R S
These results point to a role for Jbn in cilia-mediated Wnt signalling regulation. It is important to note that although Ahi1 mutant mice exhibit Wnt defects, these occur only in specific tissues and defined stages of development 33 and homeostasis 2 , whereas severe developmental Wnt phenotypes are spared. Furthermore, we have examined Ahi1 −/− ; BATgal+ mice, which exhibit grossly normal embryonic Wnt activity in most tissues (data not shown). Thus, it is clear that Jbn is not generally required for Wnt activity, and other proteins have been suggested to regulate β-catenin nuclear translocation 34 , although potential ciliary roles have not been examined. Moreover, there are now over 35 genes the mutations of which cause a range of ciliopathy phenotypes 6 , including many that overlap with Wnt phenotypes, and there is probably a high degree of compensation between the ciliopathy proteins, including Jbn.
Overall, our findings implicate a new role for cilia in spatial compartmentalization of signalling components, and specifically a mechanism for inhibition of a transcriptional regulator through sequestration at a discrete subcellular position. Strikingly, we found that although cilia presence dampens Wnt responses, retrograde IFT is necessary for this response in ciliated cells. This dual positive and negative regulation sets up a discrete range of responsiveness in ciliated cells and may help explain why particular cells (in the developing embryo) respond to Wnt ligands within a specific range of activity and others (cancer cells) exhibit out-of-control responses. This model may in part explain the predisposition of certain types of cancer cells to lose cilia 35 because this may lead to positive selection of cells with hyperactivation of the oncogenic Wnt pathway. Although we describe a previously unknown point of ciliary regulation in the pathway, others have described the regulation of Dvl (ref. 9) and proteasomal degradation of β-catenin 8 as possible mechanisms, indicating that there may be multiple points of regulation for this organelle. Whether similar spatial control is involved at these other points in the pathway or whether this type of regulation is at play in other signalling pathways remains to be determined, but our results suggest a new spatial facet to the conventional view of the Wnt signalling cascade. METHODS Plasmid constructs and materials. GFP-tagged Jbn was used as described previously 2 . The β − cat N expression construct was obtained from M. G. Rosenfeld, the Super Topflash construct was provided by R. T. Moon and Dvl-1 and β-catenin constructs were obtained from K. Willert.Ahi1 siRNA, Dnchc2 siRNA and Kif3a siRNA oligonucleotides were purchased from Invitrogen (Stealth RNAi). Dnchc2 siRNA #1: 5 -GGGCGGAUAUUUGUUGGGUUGGUAA-3 . Dnchc2 siRNA #2: 5 -GAGCAGUGUUCUCACUGAUUGAUUA-3 . Dnchc2 siRNA #3: 5 -ACUGCUGUGUCAGUUUGCAUGGUUU-3 . Kif3a siRNA #1: 5 -UCAUGUGCCUUAUCGUAACUCUAAA-3 . Kif3a siRNA #2: 5 -GACUCGUCUUCUUCAGGAUUCCUUA-3 . Kif3a siRNA #3: 5 -GCGAUAAUG-UGAAGGUUGUUGUUAG-3 . Ahi1 siRNA-a corresponds to previously 2 used oligonucleotide #2 and siRNA-b corresponds to previously used oligonucleotide #3. These siRNAs were used because of homology to the human sequence in DLD1 cells. A low-GC-content siRNA control oligonucleotide was used as a negative control (Invitrogen). Dnchc2 siRNA #1 was used for luciferase in MEFs and 293Ts. Kif3a siRNA #1 was used for luciferase in 293T cells and Kif3a siRNA #3 was used for MEFs because of greater homology (100% in the seed region). The RVxP mutant construct was generated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) to generate the following combination of mutations: R692G, V693A and P695A. Wnt3A-conditioned medium (WCM) was obtained from stably transfected L cells with Wnt3A expression vector (provided by K. Willert) and used as described previously 36 . Control medium was obtained from untransfected L cells. Aphidicolin (Sigma-Aldrich, A0781) was used at a concentration of 1 µg ml −1 from a stock solution of 1 mg ml −1 dissolved in dimethylsulphoxide, and dimethylsulphoxide was used as the vehicle control.
METHODS

Methods
Mouse lines and tissue preparation. Dnchc2
Q397Stop allele mice 14 were provided by A. S. Peterson, and Kif3a +/− mice were provided by L. S. B. Goldstein. Both lines were then crossed with BATgal+ mice 26 (a gift from S. Piccolo). Embryos from timed matings were fixed for 2 h in 4% paraformaldehyde (PFA) followed by whole-mount X-gal staining and/or embedding in 10%/7.5% gelatin/sucrose and cryosectioning at 20 µm for immunostaining. Mouse work was carried out in compliance with Institutional Animal Care and Use Committee approved protocols. X-gal staining was carried out according to a previously published protocol 37 .
Immunofluorescence microscopy. Cilia were induced in fibroblasts by serum starvation for 24 h in OptiMEM (Invitrogen). MEFs and IMCD cells were treated with WCM or control L-cell-conditioned media (LCM) diluted 1:3 in OptiMEM for 4 h for localization studies. MEFs, HEK293T, NIH3T3, DLD1, CCD-841 (CoN, untransformed) and IMCD cells (ATCC) or Dnchc2 mutant and control MEFs (obtained from A. S. Peterson) were fixed with 4% PFA for 15 min at room temperature, washed in PBS and blocked in 4% donkey serum/0.1% Triton X-100. BrdU labelling experiments were carried out by incubation with BrdU (10 µM) in the medium (serum-free for MEFs) for 16 h with WCM followed by fixation and treatment with 2 N HCl for 15 min at 37 • C before staining. Fixed cells and tissue sections were stained with primary antibodies: mouse anti-acetylated tubulin (Zymed 32-2700, 1:500), mouse anti-β-catenin (BD Transduction Labs, 610153, 1:200), rabbit anti-β-catenin (Cell Signaling, 95825, 1:200), goat antiγ-tubulin (Santa Cruz Biotechnology, sc7396, 1:100), rabbit anti-Arl13b (gift from T. Caspary, 1:1,500), rabbit anti-glutamylated tubulin (detyrosinated tubulin, Millipore, AB3201, 1:750), chicken anti-β-galactosidase (Abcam, ab9361, 1:250), rat anti-BrdU (Abcam, ab6326, 1:100), mouse anti-polyglutamylated tubulin (GT335 antibody, a gift from C. Janke, 1:1,000) and rabbit anti-Jbn (ref. 2; Quality Controlled Biochemicals, 1:200). Samples were washed and incubated in secondary antibodies (AlexaFluor donkey anti-mouse 594, donkey anti-rat 594, donkey antichicken 488, donkey anti-rabbit 488 and donkey anti-goat 647, Molecular Probes, 1:500). Hoechst was used as a nuclear stain (Molecular Probes, H3570). Images were acquired using a DeltaVision Spectris deconvolution microscope or an FV1000 Spectral Deconvolution Confocal microscope (UCSD Neuroscience Microscopy Core) and controls and Dnchc2 mutant tissues were imaged using identical settings and exposures. Quantification was carried out with ImageJ software (NIH). For quantification of nuclear β-catenin levels, ImageJ was used to generate a binary mask from Hoechst staining, which was then applied to the green channel to quantify only nuclear levels.
Cell culture and luciferase assays. 293T, 3T3, DLD1 and IMCD cells were grown in DMEM with 10% fetal bovine serum (FBS), and MEFs were grown in 15% FBS. For transient transfections of 293T cells, 3T3 cells or MEFs, Lipofectamine 2000 (Invitrogen) was used according to the manufacturer's protocol. For luciferase assays, 293T cells, Dnchc2 mutant and littermate control MEFs and an independent wild-type MEF cell line were grown in 12-well plates and transfected with Super Topflash and β-galactosidase expression plasmid at a 5:1 ratio. Cells were cotransfected in certain experiments with Jbn expression plasmid or empty vector 2 and/or with Dvl-1 expression plasmid or β-Cat N at an amount equal to Topflash plasmid DNA. For experiments involving siRNA, 5 pmol siRNA (or 15 pmol for high-dose experiments) was co-transfected with 400 ng total DNA per well according to the manufacturer's instructions. At 24 h following transfection, cells were serum starved for 12-36 h and then treated with WCM or LCM diluted 1:3 in OptiMEM, or 20 mM lithium (LiCl), or 20 mM NaCl as a negative control, to stimulate the Wnt pathway. Aphidicolin treatments (1 µg ml −1 ) were carried out with Wnt or LiCl treatments. For serum withdrawal and re-addition experiments, cells were serum starved for 24 h followed by addition of media with 15% serum. This was followed by WCM/LCM treatment or LiCl/NaCl addition for 8 h. The luciferase assay was carried out according to a previously published protocol 38 and β-galactosidase activity was measured using the Tropix Galacto-light Plus kit (Applied Biosystems, T1007). β-galactosidase was used to normalize data for transfection efficiency, and data were normalized for variability across experiments to control untreated or empty vector transfected cells. Statistical analyses included two-tailed, unpaired Student's t -tests, and Chi-square tests to calculate the P value.
Western blot and microtubule association assay. For the microtubule association assay, five P5 mice were dissected and the cerebellum was removed and homogenized in MES buffer followed by centrifugation at 20, 000g for 15 min. Supernatant was subsequently centrifuged at 150,000g for 90 min and samples were then treated with 100 mM GTP and 1 mM Taxol for 30 min at 37 • C. Samples were centrifuged through a 10% sucrose cushion and the pellet was resuspended in MES buffer and loaded on a 12% SDS-PAGE gel. Nuclear extraction was carried out as previously described 2 . Western blotting was carried out on lysates prepared in modified radioimmunoprecipitation assay (RIPA) buffer using the following antibodies: rabbit anti-Jbn (Quality Controlled Biochemicals), goat anti-DCX (Santa Cruz Biotechnology, SC-8067), rabbit Cyclin D1 (Santa Cruz Biotechnology, SC-718), mouse anti-α-tubulin (Sigma, T-6074), rabbit anti-total ERK (Upstate, 06-182), rabbit anti-Dnchc1 and rabbit anti-Dnchc2 antibodies (both provided by R. B. Vallee), mouse anti-Kif3a (Covance, MMS-198P), mouse mab414 (Abcam, 24609) and rabbit anti-Ki67 (Novocastra, NCL-Ki67p). All antibodies were used at 1:1,000 dilution in 4% milk. 
